← Leaderboards
Susan L Uprichard
Loyola University Chicago
$8,275,018
Attributed
$13,314,043
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,314,043 · 12
VA$0 · 1
By mechanism
R01$10,544,358 · 3
R21$1,997,829 · 5
R56$420,869 · 1
R03$307,215 · 2
F32$43,772 · 1
I01$0 · 1
Top collaborators
- Alan S Perelson16 shared
- Harel Dahari5 shared
- Steven J Scaglione4 shared
Most similar at Loyola University Chicago
Same institution · by research overlap
- Basmattee Boodram$4,816,495
- Harel Dahari$6,227,500
- Jonathan Ozik$2,212,458
- Susan C. Baker$11,375,181
- Timothy Spear$153,954
Others in their field
Top investigators on “Primary Carcinoma Of The Liver Cells”
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Charles M. Rice · Rockefeller University$25,448,599
- Michael Karin · University Of California, San Diego$20,421,657
- Amit Singal · Ut Southwestern Medical Center$15,537,004
- Raymond T Chung · Massachusetts General Hospital$13,602,946
- Dean W Felsher · Stanford University$13,140,261
Research focus
Primary Carcinoma Of The Liver CellsInfectionViralIn VitroAntiviral AgentsHepatitis CHepatitis C VirusVirusPlayHepatocyteDesignMolecularCellsPharmaceutical PreparationsSerumMathematical ModelTreatment ResponseVaccinesCell Culture TechniquesBaseAccountingClinically RelevantHcv CirrhosisUnited States
Grant awards (46)
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling$1,265,369
R01 · FY2025 · AI · contact PI
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling$632,809
R01 · FY2024 · AI · contact PI
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling$633,299
R01 · FY2023 · AI · contact PI
Collaborative Integration of Hepatitis B Molecular Virology and Mathematical/Computational Modeling$407,382
R01 · FY2023 · AI · contact PI
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling$653,884
R01 · FY2022 · AI · contact PI
Collaborative Integration of Hepatitis B Molecular Virology and Mathematical/Computational Modeling$414,043
R01 · FY2022 · AI · contact PI
Collaborative Integration of Hepatitis B Molecular Virology and Mathematical/Computational Modeling$420,892
R01 · FY2021 · AI · contact PI
Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C$0
I01 · FY2021 · VA · contact PI
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling$599,360
R01 · FY2020 · AI · contact PI
Collaborative Integration of Hepatitis B Molecular Virology and Mathematical/Computational Modeling$450,911
R01 · FY2020 · AI · contact PI
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling$531,382
R01 · FY2019 · AI · contact PI
Collaborative Integration of Hepatitis B Molecular Virology and Mathematical/Computational Modeling$471,058
R01 · FY2019 · AI · contact PI
Defining the biology and public health risk of HBV Genotype E$190,364
R21 · FY2019 · AI · contact PI
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling$42,299
R01 · FY2019 · AI · contact PI
Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C$0
I01 · FY2019 · VA · contact PI
Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C$0
I01 · FY2019 · VA · contact PI
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling$531,387
R01 · FY2018 · AI · contact PI
Defining the biology and public health risk of HBV Genotype E$227,375
R21 · FY2018 · AI · contact PI
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling$531,399
R01 · FY2017 · AI · contact PI
Identification of cellular factors that mediate HCV cell-to-cell spread$75,500
R03 · FY2017 · AI · contact PI
Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C$0
I01 · FY2017 · VA · contact PI
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling$544,109
R01 · FY2016 · AI · contact PI
Identification of cellular factors that mediate HCV cell-to-cell spread$75,500
R03 · FY2016 · AI · contact PI
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling$393,424
R01 · FY2014 · AI · contact PI
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling$369,819
R01 · FY2013 · AI · contact PI
Elucidating the role of the NPC1L1 cholesterol uptake receptor in HCV infection$188,750
R21 · FY2013 · AI · contact PI
The Role of Transferrin Receptor 1 in Hepatitis C virus Entry$177,425
R21 · FY2013 · AI · contact PI
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling$272,388
R01 · FY2012 · AI · contact PI
The Role of Transferrin Receptor 1 in Hepatitis C virus Entry$226,500
R21 · FY2012 · AI · contact PI
Elucidating the role of the NPC1L1 cholesterol uptake receptor in HCV infection$162,041
R21 · FY2012 · AI · contact PI
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling$138,054
R01 · FY2012 · AI · contact PI
Elucidating the role of the NPC1L1 cholesterol uptake receptor in HCV infection$72,799
R21 · FY2012 · AI · contact PI
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling$353,913
R01 · FY2011 · AI · contact PI
Development of real time fluorescence-based assays for elucidating HCV entry dyna$77,715
R03 · FY2011 · AI · contact PI
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling$420,869
R56 · FY2010 · AI · contact PI
Development of real time fluorescence-based assays for elucidating HCV entry dyna$78,500
R03 · FY2010 · AI · contact PI
Development of 3D Differentiated Hepatocyte Culture Systems for the Study of HCC$176,625
R21 · FY2009 · CA · contact PI
High Throughput in vitro Hepatitis C Virus Screening$100,000
R01 · FY2009 · AI · contact PI
High Throughput in vitro Hepatitis C Virus Screening$231,928
R01 · FY2008 · AI · contact PI
Development of 3D Differentiated Hepatocyte Culture Systems for the Study of HCC$200,550
R21 · FY2008 · CA · contact PI
High Throughput in vitro Hepatitis C Virus Screening$272,414
R01 · FY2007 · AI · contact PI
High Throughput in vitro Hepatitis C Virus Screening$39,085
R01 · FY2007 · AI · contact PI
High Throughput in vitro Hepatitis C Virus Screening$243,750
R01 · FY2006 · AI · contact PI
Developing Murine Models of HCV Replication$187,700
R21 · FY2004 · AI
Developing Murine Models of HCV Replication$187,700
R21 · FY2003 · AI
Molecular Basis of Cytokine-induced Clearance of HBV RNA$43,772
F32 · FY2001 · AI